NO921219D0 - Somatostatin reseptor - Google Patents

Somatostatin reseptor

Info

Publication number
NO921219D0
NO921219D0 NO921219A NO921219A NO921219D0 NO 921219 D0 NO921219 D0 NO 921219D0 NO 921219 A NO921219 A NO 921219A NO 921219 A NO921219 A NO 921219A NO 921219 D0 NO921219 D0 NO 921219D0
Authority
NO
Norway
Prior art keywords
receptor
somatostatin receptor
purified
somatostatin
antibodies
Prior art date
Application number
NO921219A
Other languages
English (en)
Other versions
NO921219L (no
Inventor
Cecil Mark Eppler
John Ronald Zysk
Martin John Corbett
Hong-Ming Shieh
John Hadcock
Joann Strnad
Jeffrey David Hulmes
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO921219D0 publication Critical patent/NO921219D0/no
Publication of NO921219L publication Critical patent/NO921219L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO92921219A 1991-03-28 1992-03-27 Somatostatin reseptor NO921219L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67700991A 1991-03-28 1991-03-28
US81792192A 1992-01-07 1992-01-07

Publications (2)

Publication Number Publication Date
NO921219D0 true NO921219D0 (no) 1992-03-27
NO921219L NO921219L (no) 1992-09-29

Family

ID=27101681

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921219A NO921219L (no) 1991-03-28 1992-03-27 Somatostatin reseptor

Country Status (8)

Country Link
EP (1) EP0508221A1 (no)
JP (1) JPH06211896A (no)
AU (1) AU1387092A (no)
CA (1) CA2064114A1 (no)
FI (1) FI921356A (no)
IE (1) IE920989A1 (no)
IL (1) IL101368A0 (no)
NO (1) NO921219L (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668006A (en) * 1992-07-17 1997-09-16 American Cyanamid Company Somatostatin receptors
US6096513A (en) * 1993-05-20 2000-08-01 Arch Development Corporation Polynucleotides encoding KAPPA opiod receptors
US5998154A (en) * 1995-07-07 1999-12-07 The University Of Texas System Somatostatin receptor peptide antigens and antibodies
RU2007137122A (ru) 2005-03-09 2009-04-20 Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем (Us) НОВЫЙ ПРОМОТОР hTMC И ВЕКТОРЫ ДЛЯ ОПУХОЛЕСЕЛЕКТИВНОЙ И ВЫСОКОЭФФЕКТИВНОЙ ЭКСПРЕССИИ ТЕРАПЕВТИЧЕСКИХ ПРОТИВОРАКОВЫХ ГЕНОВ

Also Published As

Publication number Publication date
IL101368A0 (en) 1992-11-15
IE920989A1 (en) 1992-10-07
NO921219L (no) 1992-09-29
FI921356A0 (fi) 1992-03-27
EP0508221A1 (en) 1992-10-14
JPH06211896A (ja) 1994-08-02
AU1387092A (en) 1992-10-01
CA2064114A1 (en) 1992-09-29
FI921356A (fi) 1992-09-29

Similar Documents

Publication Publication Date Title
BR9710435A (pt) Genes de moraxella receptores de transferrina
SE8901687D0 (sv) Fibronectin binding protein as well as its preparation
DE69518751D1 (de) Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend
DE69528061D1 (de) Gereinigte polyporus laccasen und dafür kodierende nukleinsäuren
ES2076999T3 (es) Peptidos anticoagulantes radiomarcados.
DK0491878T3 (da) Præparater til inhibering af proteinhormondannelse og anvendelser deraf
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
EP0291981A3 (en) Cyclic anticoagulant peptides
NZ224678A (en) Anticoagulant peptides
EP0680316A4 (en) NEW PROTEINS FROM PARASITIC WORMS.
FI921356A0 (fi) Somatostatinreceptor.
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
SE9602822D0 (sv) New receptor
EP0272174A3 (fr) Préparations d'adenyl cyclase purifiées, procédé d'obtention de ces préparations et leurs applications biologiques
EP0179412A3 (en) Antigenic peptide compounds
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines
LV12722A (lv) Prv-1 gene and the use thereof
IT1207800B (it) Limitatore dell'angolo di deviazione per giunti cardanici.